87789-47-7

Usage

Uses

Used in Pharmaceutical Industry:
4-(Difluoromethoxy)phenol is used as an intermediate in the synthesis of various pharmaceutical drugs for its unique chemical structure that allows for the development of new and effective medications.
Used in Agrochemical Industry:
4-(Difluoromethoxy)phenol is used as an intermediate in the synthesis of agrochemicals, contributing to the development of innovative products for agricultural applications.
Used in Organic Synthesis:
4-(Difluoromethoxy)phenol is used as a building block in organic synthesis, facilitating the creation of a wide range of chemical compounds for diverse applications.
Used in Biological Research:
4-(Difluoromethoxy)phenol is being investigated for its potential biological activity in the treatment of various diseases, indicating its potential as a therapeutic agent.

InChI:InChI=1/C7H6F2O2/c8-7(9)11-6-3-1-5(10)2-4-6/h1-4,7,10H

Upstream product

• 103-16-2 4-Benzyloxyphenol 
• 88798-08-7 1-(benzyloxy)-4-(difluoromethoxy)benzene 

Downstream Products

• 88797-83-5 O-ethyl S-propyl O-(4-difluoromethoxyphenyl)monothiophosphate 
• 1134197-98-0 4-(difluoromethoxy)-2-nitrophenol 
• 1126633-16-6 1-[4-(4-difluoromethoxy-phenoxy)-phenyl]-ethanone 
• 1126633-17-7 1-[4-(4-difluoromethoxy-phenoxy)-phenyl]-ethanone-oxime 
• 1126632-93-6 1-[4-(4-difluoromethoxy-phenoxy)-phenyl]-ethylamine 
• 1126631-64-8 pyrimidine-5-carboxylic acid (1-{1-[4-(4-difluoromethoxy-phenoxy)-phenyl]-ethylcarbamoyl}-cyclopropyl)-amide 
• 885266-93-3 2-bromo-1,4-bis(difluoromethoxy)benzene 
• 1345731-62-5 (3R,5S)-4-(4-chlorobenzoyl)-7-(difluoromethoxy)-3,5-dimethyl-2,3,4,5-tetrahydro-1,4-benzoxazepine 
• 1345731-94-3 tert-butyl {(R)-2-[2-bromo-4-(difluoromethoxy)phenoxy]-1-methylethyl}carbamate 
• 88798-12-3 2-bromo-4-(difluoromethoxy)phenol 

Relevant academic research and scientific papers

TETRAZOLE-SUBSTITUTED PYRAZOLOPYRIMIDINE INHIBITORS OF JAK KINASES AND USES THEREOF

Compounds of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined herein, and salts thereof, that are useful as JAK kinase inhibitors are described herein. Also provided are pharmac

PYRAZOLOPYRIMIDINE COMPOUNDS AS JAK INHIBITORS

Compounds and salts thereof that are useful as JAK kinse inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.

THERAPEUTIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF USE THEREOF

Compounds and salts thereof that are useful as JAK kinse inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.

Fluorinated liquid crystal compounds and liquid crystal medium containing same

The invention relates to liquid crystal compounds having a terminal structure in accordance with formula 1, 2, 3 or 4: wherein A2, A3, X1 and X2 and are defined herein. The invention further relates liquid c

Diethers of m- or p-hydroxyphenol

Diethers of m- or p-hydroxyphenol, as well as the monoethers, are prepared by reacting m- or p-tert.-butoxyphenol of the formula II STR1 with a halogen compound in the presence of a hydroxide, carbonate and/or bicarbonate of an alkali metal or alkaline ea